We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Public biotechnology 2003-the numbers.
- Authors
Lähteenmäki, Riku; Baker, Monya
- Abstract
The 50th anniversary of the discovery of DNA's structure was a good year for the biotech industry, particularly compared with 2002, when corporate scandals and drug failures dominated the news. The beginning of 2003 threatened more of the same and worse, as investors kept their money in their wallets. There were fewer liquidations and delistings, and many mid-size companies pooled resources, continuing the trend of consolidation from 2002. For the most part, investors put their money into companies with clinical products already in the pipeline, rather than into those still working on discovery.
- Subjects
NUCLEOTIDE sequence; DNA; BIOTECHNOLOGY industries; BIOTECHNOLOGY; ANNIVERSARIES; GENES; CORPORATE divestiture
- Publication
Nature Biotechnology, 2004, Vol 22, Issue 6, p665
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0604-665